Key Insights From the DEBBRAH and HER2CLIMB-02 Studies

Opinion
Video

Panelists discuss a brief overview of recent data on combination systemic therapies for the treatment of advanced HER2+ breast cancer, including studies such as DESTINY-Breast03, DEBBRAH, HER2CLIMB-02, and EMILIA, and they analyze which patient populations may benefit most from each therapy option based on the available data.

Seg09_Insights
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      1. Dr Iyengar: Please provide a brief overview of other recent data in combination systemic therapies for the treatment of advanced RCC. 
        1. DESTINY-Breast03
        2. DEBBRAH
        3. HER2CLIMB-02
        4. EMILIA
      2. Given the available data, for which patient population do you prefer each therapy option and why?
      Recent Videos
      3 experts are featured in this series.
      Future Perspectives in EGFR-Mutant Advanced NSCLC
      3 experts are featured in this series.
      Patient Perspective: Key Aspects of Supportive Care in the EGFR-Mutant Advanced NSCLC Journey
      3 experts are featured in this series.
      Comprehensive Supportive Care for EGFR-Mutant Advanced NSCLC
      3 experts are featured in this series.
      Patient Perspectives on Managing Side Effects from Amivantamab
      3 experts are featured in this series.
      Preparing Patients for Treatment: Education, Administration, and Side Effect Management with Amivantamab in EGFR-Mutant NSCLC
      3 experts are featured in this series.
      Shared Decision Making in EGFR-Mutant Advanced NSCLC
      Improving the RCC Patient Journey and Future Therapeutic Directions
      Improving the RCC Patient Journey and Future Therapeutic Directions
      Enhancing Supportive Care and Quality of Life for RCC Patients
      Enhancing Supportive Care and Quality of Life for RCC Patients
      3 experts are featured in this series.
      Navigating EGFR-Mutant Advanced NSCLC Cancer Treatment: A Patient's Journey
      3 experts are featured in this series.
      Tailoring Patient Education and Resources in EGFR-Mutant Advanced NSCLC
      Related Content
      Discussing, Managing, and Treating HER2+ Breast Cancer From the Patient’s Perspective

      Discussing, Managing, and Treating HER2+ Breast Cancer From the Patient’s Perspective

      ONCOLOGY Staff
      December 29th 2024
      Article

      In a From All Angles program, a patient and her treating physician spoke about the initial diagnosis, care coordination, communication, and the adverse effects observed.